1,720,969 research outputs found

    Exploring New Pharmacological Strategies to Treat Binge-Like Eating Behavior

    Full text link
    Binge eating disorder (BED) is the most common eating disorder. It is characterized by recurrent episodes of binge eating, during which individuals consume, in a discrete period of time, amounts of food larger than most people would eat under similar circumstances, while experiencing loss of control towards their eating behavior. BED has a strong negative impact on the functionality and quality of life, and it is associated with negative health consequences, including obesity and other psychiatric disorders. Psychological therapy is generally recommended for the treatment of BED, but unfortunately not all of the patients positively respond to this approach. Thus, pharmacological approaches are strongly required for the management of this pathology. To date, only Lisdexamfetamine dimesylate (LDX) has been approved for the treatment of BED by the Food and Drug Administration (FDA) in 2015, even though its clinical efficacy is limited by the adverse effects associated to this psychostimulant, in particular the increase in heart rate and blood pressure, which might lead to cardiovascular adverse events. The research for innovative pharmacological strategies is necessary, and the development of animal models of binge eating is a useful approach to investigate the neurobiological processes underlying binge eating behavior and to test the efficacy of innovative compounds to block binge eating episodes. Based on this premises, in this experimental thesis I tested the effects of two innovative compounds which might represent useful pharmacological agents for the treatment of binge eating behavior, and I also investigated potential neurobiological alterations underlying compulsive-like eating behavior, using an animal model of binge eating developed by Cifani et al. in 2009. This animal model involves the use of female rats, which develop a compulsive-like eating behavior towards highly palatable food (HPF), after being exposed to cycles of caloric restriction/refeeding plus a frustration stress procedure. This animal model is characterized by a high degree of face, construct and predictive validity. The first target analyzed in this thesis is the Sigma 1 receptor (σ1R), a chaperone-like protein which has been demonstrated to promote binge eating behavior. In particular, I tested the effect of a highly selective σ1R antagonist in the binge eating model of Cifani et al., observing that this compound was able to block the binge eating episode in female rats, without affecting anxiety-like and depressive-like behaviors. Thus, the results of this study evidenced that antagonism of the σ1R is a pharmacological strategy to selectively target and block the neuronal mechanisms that lead to the binge eating episode. The second target of my experimental thesis is orexin-A (OX-A) and the orexin-1 receptor (OX1R), importantly implicated in driving non-homeostatic consumption of HPF. Specifically, I tested the effect of a selective OX1R antagonist (SO1RA) developed by Idorsia Pharmaceuticals Ltd, named ACT-539313, on binge eating behavior. This compound blocked the binge eating episode in female rats under both acute and chronic administration regimens, without sign of tolerance. I also investigated by immunohistochemistry whether binge eating rats might display alterations in Orexin-A (OX-A) and Delta FosB protein expression (marker of long- term neuronal adaptation and plasticity) in multiple brain regions implicated in binge eating behavior. Rats chronically exposed to the binge eating protocol displayed a down-regulation of OX-A protein expression in different extra-hypothalamic sites, such as the central amygdala (CeA), dorsal raphe nucleus (DRN) and paraventricular nucleus of the thalamus (PVT), which could represent a protective mechanism against overconsumption of palatable food. In contrast, no changes in Delta FosB protein expression were found in all brain regions analyzed in binge eating rats. I also investigated whether chronic administration of ACT-539313 might produce changes in the expression of OX-A and delta FosB. Chronic treatment with the SO1RA led to an increase in the number of OX-A positive neurons in the hypothalamus, reflecting a compensatory increase in OX-A expression in response to the SO1RA, and also to an increase in the number of hypothalamic delta-FosB positive cells, suggesting activation of populations of neurons in the hypothalamus. Collectively, these results support the use of SO1RAs in the treatment of binge eating, with efficacy observed even under chronic administration regimen. Furthermore, changes in OX-A protein expression at extra-hypothalamic brain regions appear to represent a marker of binge eating behavior. In conclusion, the data obtained in my experimental thesis provide novel insights about the potential role of the σ1R and OX1R in driving binge eating behavior, and support the clinical evaluation of antagonists of these receptors in humans affected by BED

    Going Beyond Counting First Authors in Author Co-citation Analysis

    Full text link
    The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed

    Variations on the Author

    Full text link
    “Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship

    Appropriate Similarity Measures for Author Cocitation Analysis

    Full text link
    We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis

    Dispelling the Myths Behind First-author Citation Counts

    Full text link
    We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more sophisticated methods

    Author Index

    No full text
    Nao informado

    koamabayili/VECTRON-author-checklist: VECTRON author checklist

    No full text
    We have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
    corecore